Globalisation on pause? How scaleups can navigate today's uncertainty
9:30 am - 10:30 amOur offices
Business funding in Cambridge
Ask about funding
£
240
m
Invested in Cambridge since 2011
4
Experienced investors in the Cambridge office
42
Businesses backed in and around Cambridge
BGF has a proud history of working with businesses and entrepreneurs in Cambridge and the surrounding area. We have actively engaged with entrepreneurs and opportunities across the region since the inception of BGF in 2011.
In 2019, BGF opened its first Cambridge office, enabling us to expand our team and strengthen our focus on established small and medium-sized enterprises, offering an entrepreneur-friendly business funding option for growing businesses. We continue to work with businesses across all sectors, while actively extending our support for earlier stage life science and tech businesses who have ambitious growth plans.
With an evergreen balance sheet, BGF is not a traditional investment fund. Our model is to invest as a minority shareholder without imposing exit deadlines or strict timelines for exit. This allows us to closely partner with founders and management teams, enabling them to set the pace for growth, and, crucially, retain control.
See what we do and learn how we provide a source of funding that’s different by design. You can review our portfolio and read success stories of businesses like yours that have joined our Cambridge portfolio.
Funding businesses in Cambridge
DefiniGEN closed a £3.25m funding round in 2020, including £2m from BGF, alongside its existing investors led by 24Haymarket.
- DefiniGEN is a spin-out from the University of Cambridge, creating highly predictive disease cell models for preclinical research and drug development.
- BGF's funding is being used to broaden DefiniGEN's gene-editing capabilities and expand into the US.
BGF invested £2m in MIP Diagnostics as part of a co-investment with Mercia Asset Management, Downing Ventures and Calculus Capital.
- MIP Diagnostics was originally founded in 2015 as a spin out from the University of Leicester Chemistry Department to commercialise the ground-breaking advancements in nano MIP technology.
- The funding will be used to accelerate its global expansion and scale-up its manufacturing capacity.
Early Stage investment
- BGF invested £4m in PredictImmune as part of a joint funding package in 2019.
- The company specialises in prognostic tools for guiding treatment of immune-mediated diseases such as Crohn’s disease.
- Our investment has supported PredictImmune’s international commercial operations and continued development of new tools.
We are thrilled to be strengthening our presence in Cambridge, in response to the volume of interesting businesses we see in the region. Cambridge is a clear hub for innovation across a broad array of sectors, and we are excited to be partnering with local teams at the forefront of their fields.
Tim Rea
Head of Early Stage
Tim Rea
Head of Early Stage / Cambridge, Central & East
Lucy Edwardes-Jones
Investor / Early Stage / Cambridge / London / Cambridge, London
Nathan Heath
Investor / Growth / Central & East / Central & East
Mark Nunny
Investor / Growth / Central & East / Cambridge, Central & East
Elena Kovalikhina
Investor / Growth / Central & East / Central & East
Business investment in the Cambridge area
We invest across all industries. If you have further plans for growth and want to find out more about the capital and business support we provide, please get in touch.
Our office
- +44 1223 645396
-
50-60
Station Road
Cambridge, Cambridgeshire
CB1 2JH
